21st December 2022 8:47:19 AM
1 min readFollowing a progressive strengthening of the Ghana cedi versus the major trading currencies, the Pharmaceutical Society of Ghana (PSGH) has urged its members to lower drug costs.Although the primary cause of the high pricing was primarily the recent devaluation of the Cedi, the PSGH noted that drug prices were still high despite the Cedi's appreciation in a statement.
0
The PSGH wants to emphasize that the pharmaceutical industry also offers a significant, maybe life-saving, societal benefit.Access to medicines and other medical products must therefore be of utmost priority at every point in time for all relevant stakeholders, it said.
1
The statement called on PSGH actors of the pharmaceutical supply chain, including manufacturers, importers, wholesalers, suppliers, and retailers to take urgent steps to reduce the prices of medicines to reflect Cedi’s improved performance against the major trading currencies.
2
The PSGH also urged the National Health Insurance Authority (NHIA), the Ministry of Health (MOH), and the Ministry of Finance (MOF) to urgently work together to ensure payment of arrears owed to providers under the National Health Insurance Scheme (NHIS).This it said would allow providers to pay their suppliers of pharmaceutical products.
3
“We believe this will also contribute further to the reduction in prices of medicines,” it said.
4
1 min read
2 mins read
2 mins read
1 min read
1 min read
2 mins read
1 min read
2 mins read
1 min read